2015 - 2017年伊朗卫生部CDC与VAERS数据乙型肝炎疫苗AEFI比较研究

Vaccine Research Pub Date : 2021-06-01 DOI:10.52547/vacres.8.1.52

Hamidreza Hozouri, Alireza Shamsian, M. Aghasadeghi, D. Doroud

{"title":"2015 - 2017年伊朗卫生部CDC与VAERS数据乙型肝炎疫苗AEFI比较研究","authors":"Hamidreza Hozouri, Alireza Shamsian, M. Aghasadeghi, D. Doroud","doi":"10.52547/vacres.8.1.52","DOIUrl":null,"url":null,"abstract":"of rHBV, with those in The The most common adverse after administration of rHBV, manufactured by Pasteur of Iran was injection site reactions and no life threatening adverse event was observed. Conclusion: Despite reports by VAERS indicating that HBV can cause adverse events and even death in the United States, no such adverse effects were observed in rHBV in","PeriodicalId":52727,"journal":{"name":"Vaccine Research","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2021-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Comparative Study of AEFI of Hepatitis B Vaccine between Iran Ministry of Health CDC and VAERS Data during 2015 to 2017\",\"authors\":\"Hamidreza Hozouri, Alireza Shamsian, M. Aghasadeghi, D. Doroud\",\"doi\":\"10.52547/vacres.8.1.52\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"of rHBV, with those in The The most common adverse after administration of rHBV, manufactured by Pasteur of Iran was injection site reactions and no life threatening adverse event was observed. Conclusion: Despite reports by VAERS indicating that HBV can cause adverse events and even death in the United States, no such adverse effects were observed in rHBV in\",\"PeriodicalId\":52727,\"journal\":{\"name\":\"Vaccine Research\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Vaccine Research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.52547/vacres.8.1.52\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vaccine Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.52547/vacres.8.1.52","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

伊朗巴斯德公司生产的rHBV给药后最常见的不良反应是注射部位反应，未观察到危及生命的不良事件。结论：尽管VAERS的报告表明HBV在美国会引起不良事件甚至死亡，但在

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Comparative Study of AEFI of Hepatitis B Vaccine between Iran Ministry of Health CDC and VAERS Data during 2015 to 2017

of rHBV, with those in The The most common adverse after administration of rHBV, manufactured by Pasteur of Iran was injection site reactions and no life threatening adverse event was observed. Conclusion: Despite reports by VAERS indicating that HBV can cause adverse events and even death in the United States, no such adverse effects were observed in rHBV in

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Vaccine Research

自引率

0.00%

发文量

审稿时长

15 weeks